Aim: The following case series aims to highlight and put forth the various outcomes of alcohol use disorders (AUDs) and coronavirus disease-2019 (COVID-19).
Background: The hazardous and well-established relation of how alcohol damages every functional component of the human body, plays a vital role in understanding the enormously severe effects it can have with a comorbid infection especially COVID-19. Tagged along come the various degrees of complications ranging from mild to severe, the latter being the most common.
Case descriptions: This case series presents three cases with AUDs succumbing to COVID-19 infection eventually having unfavorable outcomes.
Conclusion: Patients with AUDs are not only prone to acquire COVID-19 infection, the chances of having complications are not unlikely.
Clinical significance: A better understanding of AUD and COVID-19 including the etiopathogenesis, should be emphasized on and management plans for better outcomes should be put forth. Establishing protocols and being vigilant of what to expect in such cases serves of utmost value.
Coronavirus disease (COVID‐19). Events as they happen. 2020. Avaiable from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
Keyes KM, Hatzenbuehler ML, Hasin DS. Stressful life experiences, alcohol consumption, and alcohol use disorders: the epidemiologic evidence for four main types of stressors. Psychopharmacology 2011;218(1):1–17. DOI: 10.1007/s00213-011-2236-1.
Simou E, Britton J, Leonardi-Bee J. Alcohol and the risk of pneumonia: a systematic review and meta-analysis. BMJ Open 2018;8(8):e022344. DOI: 10.1136/bmjopen-2018-022344.
Da BL, Im GY, Schiano TD. COVID-19 hangover: a rising tide of alcohol use disorder and alcohol-associated liver disease. Hepatology 2020;73(3):1102–1108. DOI: 10.1002/hep.31307.
Finlay I, Gilmore I. Covid-19 and alcohol—a dangerous cocktail. BMJ 2020;369:m1987. DOI: 10.1136/bmj.m1987.
Clay JM, Parker MO. Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? Lancet Public Health 2020;5(5):e259. DOI: 10.1016/S2468-2667(20)30088-8.
Cardet JC, White AA, Barrett NA, et al. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract 2014;2(2):208–213. DOI: 10.1016/j.jaip.2013.12.003.
Cardoso FS, Pereira R, Germano N. Liver injury in critically ill patients with COVID-19: a case series. Crit Care 2020;24(1):190. DOI: 10.1186/s13054-020-02924-4.
Filatov A, Sharma P, Hindi F, et al. Neurological complications of coronavirus disease (covid-19): encephalopathy. Cureus 2020;12(1):e7352. DOI: 10.7759/cureus.7352.
Global COVID-19 clinical platform novel coronavirus (COVID-19)—rapid version. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/who-ncov-crf.pdf?sfvrsn=84766 e69_2.
D’Adamo H, Yoshikawa T, Ouslander JG. Coronavirus disease 2019 in geriatrics and long-term care: the ABCDs of COVID19. J Am Geriatr Soc 2020;68(5):912–917. DOI: 10.1111/jgs.16445.
LaHue SC, James TC, Newman JC, et al. Collaborative delirium prevention in the age of COVID-19. J Am Geriatr Soc 2020;68(5):947–949. DOI: 10.1111/jgs.16480.
Yeligar SM, Chen MM, Kovacs EJ, et al. Alcohol and lung injury and immunity. Alcohol 2016;55:51–59. DOI: 10.1016/j.alcohol.2016.08.005.
Szabo G, Saha B. Alcohol's effect on host defense. Alcohol Res 2015;37:159–170. PMID: 26695755; PMCID: PMC4590613.
Camargo Moreno M, Lewis JB, Kovacs EJ, et al. Lung allograft donors with excessive alcohol use have increased levels of human antimicrobial peptide LL-37. Alcohol 2019;80:109–117. DOI: 10.1016/j.alcohol.2018.11.003.
Inciardi RM, Lupi L, Zaccone G. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5(7):819–824. DOI: 10.1001/jamacardio.2020.1096.
Zampino R, Mele F, Florio LL, et al. Liver injury in remdesivir-treated COVID-19 patients. Hepatol Int 2020;14(5):881–883. DOI: 10.1007/s12072-020-10077-3.
Lagisetty PA, Maust D, Heisler M, et al. Physical and mental health comorbidities associated with primary care visits for substance use disorders. J Addict Med 2017;11(2):161–162. DOI: 10.1097/ADM.0000000000000280.